215 related articles for article (PubMed ID: 8968344)
1. Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue.
Müller-Ehmsen J; Brixius K; Hoischen S; Schwinger RH
J Pharmacol Exp Ther; 1996 Dec; 279(3):1220-8. PubMed ID: 8968344
[TBL] [Abstract][Full Text] [Related]
2. Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue.
Brixius K; Mohr V; Müller-Ehmsen J; Hoischen S; Münch G; Schwinger RH
Br J Pharmacol; 1998 Sep; 125(1):41-8. PubMed ID: 9776342
[TBL] [Abstract][Full Text] [Related]
3. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
Schwinger RH; Böhm M; Schulz C; Schmidt U; Schmidt U; Schmid B; Dienemann H; Reichart B; Erdmann E
J Pharmacol Exp Ther; 1993 Apr; 265(1):346-57. PubMed ID: 8386240
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil-induced vasorelaxation: functional evidence for K+ channel-dependent and cyclic GMP-dependent components in a single vascular preparation.
Meisheri KD; Cipkus-Dubray LA; Hosner JM; Khan SA
J Cardiovasc Pharmacol; 1991 Jun; 17(6):903-12. PubMed ID: 1714013
[TBL] [Abstract][Full Text] [Related]
5. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
Borg C; Mondot S; Mestre M; Cavero I
J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
[TBL] [Abstract][Full Text] [Related]
6. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen.
Magnon M; Durand I; Cavero I
J Pharmacol Exp Ther; 1994 Mar; 268(3):1411-8. PubMed ID: 7908056
[TBL] [Abstract][Full Text] [Related]
7. Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
Schwinger RH; Böhm M; Koch A; Morano I; Rüegg JC; Erdmann E
J Pharmacol Exp Ther; 1994 May; 269(2):778-86. PubMed ID: 8182546
[TBL] [Abstract][Full Text] [Related]
8. Increased vascular selectivity and prolonged pharmacological efficacy of the L-type Ca2+ channel antagonist lercanidipine in human cardiovascular tissue.
Brixius K; Gross T; Tossios P; Geissler HJ; Mehlhorn U; Schwinger RH; Hekmat K
Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):708-13. PubMed ID: 16173926
[TBL] [Abstract][Full Text] [Related]
9. Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts.
Schwinger RH; Hoischen S; Reuter H; Hullin R
J Mol Cell Cardiol; 1999 Jan; 31(1):283-96. PubMed ID: 10072735
[TBL] [Abstract][Full Text] [Related]
10. The risk of myocardial stunning is decreased concentration-dependently by KATP channel activation with nicorandil before high K+ cardioplegia.
Sugimoto S; Iwashiro K; Monti F; Dawodu AA; Schiariti M; Puddu PE
Int J Cardiol; 1995 Jan; 48(1):11-25. PubMed ID: 7744533
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
Schwinger RH; Müller-Ehmsen J; Böhm M; Erdmann E
J Pharmacol Exp Ther; 1996 Mar; 276(3):1180-8. PubMed ID: 8786551
[TBL] [Abstract][Full Text] [Related]
12. [Effects of nicorandil, a potassium agonist, on the human umbilical artery. Role of the vascular endothelium].
Tiritilli A; Levy P; Haïat R
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1095-9. PubMed ID: 8572852
[TBL] [Abstract][Full Text] [Related]
13. Vasodilative effect of nicorandil on coronary artery.
Miyazaki Y; Ogawa K; Satake T; Sugiyama S; Ozawa T
Arzneimittelforschung; 1985; 35(2):504-7. PubMed ID: 3158319
[TBL] [Abstract][Full Text] [Related]
14. Effects of the new potassium channel opener JTV-506 on coronary vessels in vitro and in vivo.
Hirata Y; Kanada A; Miyai H; Mabuchi Y; Aisaka K
Arzneimittelforschung; 1999 Mar; 49(3):199-206. PubMed ID: 10219462
[TBL] [Abstract][Full Text] [Related]
15. KATP channel activation mediates nicorandil-induced relaxation of nitrate-tolerant coronary arteries.
O'Rourke ST
J Cardiovasc Pharmacol; 1996 Jun; 27(6):831-7. PubMed ID: 8761850
[TBL] [Abstract][Full Text] [Related]
16. Acute dilatory and negative inotropic effects of homocysteine are inhibited by an adenosine blocker.
Kennedy RH; Owings R; Joseph J; Melchert RB; Hauer-Jensen M; Boerma M
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):340-4. PubMed ID: 16620298
[TBL] [Abstract][Full Text] [Related]
17. Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways.
Pérez-Vizcaíno F; Cogolludo AL; Villamor E; Tamargo J
Br J Pharmacol; 1998 Mar; 123(5):847-54. PubMed ID: 9535012
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia.
Sugimoto S; Puddu PE; Monti F; Schiariti M; Campa PP; Marino B
J Thorac Cardiovasc Surg; 1994 Sep; 108(3):455-66. PubMed ID: 8078338
[TBL] [Abstract][Full Text] [Related]
19. Effects of nicotinamide on cardiac contraction force and slow inward current.
Mao XM; Li DM; Zhou CM; Wang XW; Zhang KJ
Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):514-6. PubMed ID: 7516609
[TBL] [Abstract][Full Text] [Related]
20. Relaxant effect of nicorandil on the tonic contraction of the canine large coronary artery induced by phorbol 12,13-dibutylate.
Kuromaru O; Sakai K
Arch Int Pharmacodyn Ther; 1995; 330(1):25-38. PubMed ID: 8849308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
